Lehrstuhl für Geburtshilfe und Frauenheilkunde


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Cross-sectional study on user requirements for developing a digital patient navigator app (2025) Seitz K, Langbein M, Goossens C, Altmannshofer S, Fasching P, Hack C, Heindl F, et al. Journal article Ribociclib Plus Endocrine Therapy in Hormone Receptor-Positive/ERBB2-Negative Early Breast Cancer: 4-Year Outcomes From the NATALEE Randomized Clinical Trial (2025) Fasching P, Stroyakovskiy D, Yardley DA, Huang CS, Crown J, Bardia A, Chia S, et al. Journal article Assessing the catchment area of German comprehensive cancer centers by merging geographic healthcare data - an initiative of the ONCOnnect consortium (2025) Kerscher A, Metzler M, Kapitza J, Bernhardt L, Dedner K, Krebs M, Brandts CH Journal article Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer (2025) Michel LL, Ziegler P, Kreis P, Hartkopf AD, Wallwiener M, Häberle L, John N, et al. Journal article Erratum: Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus (Nature communications (2016) 7DOI: 10.1038/ncomms12675.) (2025) Lawrenson K, Kar S, McCue K, Kuchenbaeker K, Michailidou K, Tyrer J, Beesley J, et al. Journal article, Erratum The Epidemiology of Cervical Cancer in Germany: A Registry-Based Analysis of Incidence, Survival, and Tumor Characteristics (2003–2021) (2025) Stübs F, Beckmann M, Pöschke P, Heindl F, Emons J, Gaß P, Häberle L Journal article Reply to: Germline and Somatic BRCA1/2 Mutations in Breast Cancer Treatment Strategies (2025) Hahnen E, Hauke J, Gelmon K, Marmé F, Ernst C, Martin M, Untch M, et al. Journal article, Letter The SURVIVE study (NCT05658172): Bringing breast cancer aftercare to the 21stcentury: Study protocol of a Phase III clinical trial comparing liquid biopsy guided vs. Standard of care surveillance for intermediate to high-risk breast cancer survivors (2025) Braun T, Huesmann S, Pfister K, Friedl TW, Hartkopf A, Pantel K, Mehmeti F, et al. Journal article Limited association between HRR gene alterations and HRD in molecular tumor board cancer samples: Who should be tested for HRD? (2025) Schubart C, Tögel L, Carta MG, Hetzner P, Helbig L, Zaglas C, Ziegler M, et al. Journal article Adherence to digital pregnancy care – lessons learned from the SMART start feasibility study (2025) Jäger K, Nissen M, Leutheuser H, Danzberger N, Titzmann A, Pontones C, Goossens C, et al. Journal article